Not Yet Recruiting
Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma
NCT07543510
- Conditions
- Adenocarcinoma, Atezolizumab Plus Bevacizumab, Carcinoma, +11 more
- Locations
-
Not specified